Penn Center for Innovation

Nine Philly companies on the cutting edge of cell and gene therapy innovation

Posted on May 11, 2020 — Jessica Jones Gupta

The list from Philadelphia Magazine includes five Penn spinouts: Cabaletta Bio, Carisma Therapeutics, Passage Bio, Spark Therapeutics and Tmunity Therapeutics. Read the full article

Headway, a communication device for minimally invasive surgery, wins 2020 Pennvention Grand Prize

Posted on — Jessica Jones Gupta

Now in its fifteenth year, Pennvention prides itself on being the sole Penn entrepreneurship competition with a primary focus on technological innovation. Over the course of the competition, entrants pitch an idea, develop a product, receive help from mentors and enter to win over $20,000 in prizes. This year’s winner was Headway, a wearable device for…

Nikil Ragav wants to bring high-tech, hands-on learning to all students

Posted on May 8, 2020 — Jessica Jones Gupta

“The goal is to provide this type of learning to every school in America regardless of its location or income level of its students, especially in underserved communities.” – Nikil Ragav winner of the Penn President’s Innovation Prize and fall 2019 I-Corps graduate.   Read more on Penn Today

Exciting expansion of Penn startup Passage Bio with Penn’s Gene Therapy Program led by Dr. Jim Wilson

Posted on May 7, 2020 — Jessica Jones Gupta

Passage Bio emerged early last year with a sizable war chest, five gene therapy programs from the University of Pennsylvania and the option to license seven more. Now, the company is doubling down on that partnership, promising the university $5 million a year in exchange for access to more programs and new technologies that come out of…

Coming together to solve the many scientific mysteries of COVID-19

Posted on May 6, 2020 — Jessica Jones Gupta

Putting some of their regular research projects on the back burner, researchers around Penn are digging into unknowns about the novel coronavirus from their deep and varied perspectives. To dig into what scientists around campus are asking and learning, Penn Today spoke with several who have pivoted their research to focus on COVID-19. Their work,…

Penn Medicine checks on self-isolated patients via daily texts

Posted on April 30, 2020 — Jessica Jones Gupta

Some Philly medical professionals are now able to keep track of their coronavirus patients who are self-isolating at home through automatic daily texts. COVID-Watch is a new text-message tool Penn Medicine is using to assess a patient’s medical condition. Read the newradio kyw article Visit the COVID-Watch website.

Strella Biotechnology, a Penn I-Corps graduate, raised $3.3 million in its seed funding round

Posted on — Jessica Jones Gupta

A Philadelphia-based agricultural biotech startup, founded by a University of Pennsylvania graduate looking to solve the global problem of food waste, has raised $3.3 million in its seed funding round from a group of investors that includes entrepreneur Mark Cuban. The investment in Strella Biotechnology was led by California-based venture capital firm Yamaha Motor Ventures & Laboratory Silicon…

ProNoto: Eliminating the clutter to focus on the medicine

Posted on April 23, 2020 — Jessica Jones Gupta

Health care priorities have shifted suddenly for professionals and researchers worldwide as dedicated focus is required for solving one problem: the spread and mitigation of the coronavirus. There are new studies, guidelines, and frontline recommendations emerging at record speed, and along with the difficulty of treating COVID patients, our health care providers also need to…

Pennovation Works’ first managing director on campus expansion plans, Covid-19 challenges

Posted on April 22, 2020 — Jessica Jones Gupta

For the first time since launching Pennovation Works more than eight years ago, the University of Pennsylvania has hired a managing director to oversee the 23-acre hub of innovation and entrepreneurial activity. Anish Kumar was hired late last year but Penn is just announcing his appointment. A few months on the job, Kumar said joining Pennovation…

FDA approval of Passage Bio orphan drug

Posted on April 21, 2020 — Jessica Jones Gupta

FDA grants Passage Bio orphan drug designation for PBGM01 for treatment of infantile GM1 Gangliosidosis. Read More.